It is a pharma private limited company based in Palwal, Haryana, India, established in 2000.
2000 | Palwal, Haryana, India | ActiveGlobin Pharmaceuticals Private Limited, a active private limited company, was established on 23 March 2000 in Palwal, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239HR2000PTC034453. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Employing 8 professional, Its leadership includes Vipin Wadhwa (Director), Sanjay Wadhwa (Director). Past directors included Ravi Prakash Khandelwal, Sama Ramesh Reddy, Arun Kumar Garg. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No.8 Civil Lines, Palwal, Haryana, 121101.
U24239HR2000PTC034453
034453
23 March 2000
₹3.00 M
₹3.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Globin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vipin Wadhwa | Director | 22 Dec 2005 | Current |
| Sanjay Wadhwa | Director | 22 Dec 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Aug 2009 | Past |
| Pramod Abcsdd | Director | 11 Aug 2009 | Past |
| Pramod Abcsdd | Director | 05 Jun 2009 | Past |
| Pramod Abcsdd | Managing Director | 16 Nov 2008 | Past |
| Pramod Abcsdd | Director | 16 Mar 2009 | Past |
| Pramod Abcsdd | Director | 18 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Globin Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.04% increase. The company also saw a slight improvement in profitability, with a 0.95% increase in profit. The company's net worth Soared by an impressive increase of 17.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Globin Pharmaceuticals had a public holding of 63.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2007 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Globin Pharmaceuticals has a workforce of 8 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Globin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Globin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Globin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on A charge with Others of Rs. 10.00 M registered on 02 Jul 2007 with Charge ID 10057181 was modified on 18 Apr 2022. was documented.
Progress on A charge with Others amounted to Rs. 10.00 M with Charge ID 10057181 was registered on 02 Jul 2007. was documented.
Progress on Vipin Wadhwa was appointed as a Director was appointed as a Director on 22 Dec 2005 & has been associated with this company since 19 years 11 months . was documented.
Sanjay Wadhwa was appointed as a Director was appointed as a Director on 22 Dec 2005 & has been associated with this company since 19 years 11 months . was recorded as a recent event.
The CIN of Globin Pharmaceuticals Private Limited is U24239HR2000PTC034453.
Globin Pharmaceuticals Private Limited is headquartered at House No.8 Civil Lines, Palwal, Haryana, 121101.
Globin Pharmaceuticals Private Limited was incorporated on 23 March 2000.
The current directors of Globin Pharmaceuticals Private Limited are
The primary industry of Globin Pharmaceuticals Private Limited is Manufacturing.
Globin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Globin Pharmaceuticals Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Globin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX